Background Somatostatin analog functional imaging with gallium‐68 (Ga‐68) dotatate
positron emission tomography/computed tomography (PET/CT) has demonstrated …

Objective: To evaluate the impact of 68 Ga-DOTATOC positron emission tomography
(PET)/computed tomography (CT) on the multimodal management of neuroendocrine …

Objectives The aim of the present review was to assess the role of combined 18 F-
Fluorodeoxyglucose (F-18 FDG) and Ga-68 DOTA-peptides positron emission tomography …

Neuroendocrine tumors (NETs) are rare neoplasms that emerge mainly from the GI tract,
pancreas and respiratory tract. The incidence of NETs has increased more than sixfold in the …

Background 68 Gallium-DOTATATE positron emission tomography–computed tomography
(PET CT) has shown superior accuracy in detecting grade 1 and 2 neuroendocrine tumors …

Several authors reported the superiority of 68Ga-DOTANOC PET/CT to conventional
imaging (CI) for the assessment of neuroendocrine tumors (NET). However, the detection of …

This study aimed to assess the clinical impact of 68Ga-DOTATATE and 18F-FDG with
respect to the management plan and to evaluate the prognostic value of both tracers …

Aim: Retrospective evaluation of the impact of integrated positron emission
tomography/computed tomography (PET/CT) using 68Ga-DOTA (0)-Phe (1)-Tyr (3) …

68Ga-DOTATOC, a somatostatin receptor–targeted ligand, has been used clinically in
Europe over the past decade for imaging neuroendocrine tumors (NETs). It appears to be …

68Ga-DOTATATE PET/CT scanning is a widely accepted method for imaging of
neuroendocrine tumors. This cross-sectional study was performed to review the first 8 y of …